Comerica Bank’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Comerica Bank’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$7.7K	Buy	+294	New	+$7.56K	﹤0.01%	3303
2025 Q2	–	Sell	-301	Closed	-$6.17K	–	3742
2025 Q1	$6.17K	Buy	+301	New	+$6.72K	﹤0.01%	3285
2024 Q3	–	Sell	-84	Closed	-$1.95K	–	3716
2024 Q2	$1.95K	Buy	+84	New	+$1.97K	﹤0.01%	3500
2023 Q4	–	Sell	-736	Closed	-$15K	–	3777
2023 Q3	$15K	Buy	+736	New	+$16.5K	﹤0.01%	3086

Other funds holding IDNA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Comerica Bank's IDNA Position: Q4 2025 in Review

Comerica Bank opened a new position in iShares Genomics Immunology and Healthcare ETF (IDNA) in Q4 2025: 294 shares worth $7.7K. The stake represents ﹤0.01% of the portfolio and ranks #3303 among its holdings. This is a return to the name: Comerica Bank previously reported a position in IDNA as recently as Q1 2025.

Comerica Bank first reported a position in IDNA in Q3 2023 and has held it in 4 quarters since. The position peaked at $15K in Q3 2023. 58 funds tracked by Wall St. Rank hold IDNA as of Q4 2025.

Comerica Bank held 294 shares of iShares Genomics Immunology and Healthcare ETF worth $7.7K as of Q4 2025.
iShares Genomics Immunology and Healthcare ETF was a new Comerica Bank position in Q4 2025.
iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3303 holding.
Comerica Bank first reported a position in iShares Genomics Immunology and Healthcare ETF in Q3 2023 and has held it in 4 quarters since.
Comerica Bank's iShares Genomics Immunology and Healthcare ETF position peaked at $15K in Q3 2023.
58 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.